SmartCella enters agreement to advance Professor Johan Ericson’s research on cell replacement therapies for Parkinson’s disease February 13, 2025 10:00 CET
SmartCella tecknar avtal för vidareutveckling av professor Johan Ericsons forskning kring stamcellbaserad behandling av Parkinsons sjukdom February 13, 2025 10:00 CET
SmartCella granted new European patent for the Extroducer delivery platform November 12, 2024 08:45 CET
XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart July 10, 2024 14:08 CEST
Senior life science and medical specialists join SmartCella’s Board of Directors June 12, 2024 09:00 CEST
SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies February 7, 2024 09:00 CET
SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer January 3, 2024 11:33 CET
SmartCella Holding AB raises SEK 328 million to advance and accelerate development of the company’s technologies September 27, 2021 13:23 CEST
Procella Therapeutics and Smartwise enter collaboration with AstraZeneca to develop novel cardiovascular and catheter-based therapies May 7, 2018 16:03 CEST